![Cabergoline - A New Dopamine Agonist for the Therapy of Prolactinoma - NEPTCC Bulletin Newsletter Article - MGH Neuroendocrine and Pituitary Tumor Clinical Center - Massachusetts General Hospital - Harvard Medical School (HMS) Cabergoline - A New Dopamine Agonist for the Therapy of Prolactinoma - NEPTCC Bulletin Newsletter Article - MGH Neuroendocrine and Pituitary Tumor Clinical Center - Massachusetts General Hospital - Harvard Medical School (HMS)](https://pituitary.mgh.harvard.edu/images/e-s-962a.gif)
Cabergoline - A New Dopamine Agonist for the Therapy of Prolactinoma - NEPTCC Bulletin Newsletter Article - MGH Neuroendocrine and Pituitary Tumor Clinical Center - Massachusetts General Hospital - Harvard Medical School (HMS)
![Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases](https://www.frontiersin.org/files/Articles/416881/fendo-09-00625-HTML/image_m/fendo-09-00625-g001.jpg)
Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases
Does Cabergoline Help in Decreasing Chronic Pelvic Pain Due to Endometriosis Compared to Medroxyprogesterone Acetate? A Prospect
![Treatment with Cabergoline Is Associated with Weight Loss in Patients with Hyperprolactinemia - Korner - 2003 - Obesity Research - Wiley Online Library Treatment with Cabergoline Is Associated with Weight Loss in Patients with Hyperprolactinemia - Korner - 2003 - Obesity Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9dc4345a-9903-411f-bcac-f2de2c4c8e3c/oby_311_f1.gif)
Treatment with Cabergoline Is Associated with Weight Loss in Patients with Hyperprolactinemia - Korner - 2003 - Obesity Research - Wiley Online Library
![Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study | International Journal of Impotence Research Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study | International Journal of Impotence Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.ijir.3901476/MediaObjects/41443_2006_Article_BF3901476_Fig1_HTML.gif)
Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study | International Journal of Impotence Research
![A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea | NEJM A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1994/nejm_1994.331.issue-14/nejm199410063311403/production/images/img_medium/nejm199410063311403_t3.jpeg)